Q1 2022 Holdings
Filed 2022-05-16 | 42 holdings | $67.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $16.4M | 140,000 | 24.3% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $12.7M | 1,700,000 | 18.8% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $10.2M | 300,000 | 15.1% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $7.4M | 110,000 | 10.9% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $5.7M | 350,000 | 8.4% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $4.4M | 100,000 | 6.5% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $3.9M | 94,500 | 5.8% |
| Aadi Bioscience Inc(WHWK) | COM | 00032Q104 | $2.5M | 150,000 | 3.8% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $2.2M | 125,000 | 3.2% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $1.9M | 85,000 | 2.8% |
| Spdr S&P 500 ETF TR(SPY)Put | TR UNIT | 78462F103 | $225.8K | 500,000 | 0.3% |
| Spdr SER TR(XBI)Call | S&P BIOTECH | 78464A870 | $27.0K | 300,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $12.7K | 250,000 | 0.0% |
| Merus N V | COM | N5749R100 | $10.6K | 400,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $10.4K | 1,100,000 | 0.0% |
| Sierra Oncology Inc | COM NEW | 82640U404 | $10.4K | 325,000 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $8.6K | 466,403 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $7.6K | 60,000 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $7.6K | 450,000 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $7.2K | 300,000 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $6.6K | 400,000 | 0.0% |
| Axsome Therapeutics Inc(AXSM)Put | COM | 05464T104 | $6.2K | 150,000 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $6.1K | 1,300,000 | 0.0% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $5.5K | 250,000 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $3.9K | 225,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $3.9K | 50,000 | 0.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $3.7K | 750,000 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $3.7K | 80,000 | 0.0% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $3.2K | 200,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $3.2K | 200,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $3.1K | 100,000 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $2.7K | 100,000 | 0.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $2.0K | 120,000 | 0.0% |
| 9 Meters Biopharma Inc | COM | 654405109 | $1.9K | 3,250,000 | 0.0% |
| Satsuma Pharmaceuticals Inc | COM | 80405P107 | $1.8K | 473,562 | 0.0% |
| Leap Therapeutics Inc | COM | 52187K101 | $1.7K | 993,714 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $1.6K | 20,000 | 0.0% |
| Vistagen Therapeutics Inc(VTGNUSD) | COM NEW | 92840H202 | $1.6K | 1,315,154 | 0.0% |
| Aeglea Biotherapeutics Inc(AGLEUSD) | COM | 00773J103 | $1.6K | 686,599 | 0.0% |
| Pardes Biosciences Inc | COM | 69945Q105 | $614 | 85,000 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $405 | 100,000 | 0.0% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $303 | 75,000 | 0.0% |